ENTRY       D11947                      Drug
NAME        Efpeglenatide (USAN/INN)
FORMULA     C2415H3715N663O743S17(C2H4O)n
SEQUENCE    (Chain A)
            PSCPAPEFLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SQEDPEVQFN WYVDGVEVHN
            AKTKPREEQF NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK GLPSSIEKTI SKAKGQPREP
            QVYTLPPSQE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL
            YSRLTVDKSR WQEGNVFSCS VMHEALHNHY TQKSLSLSLG K
            (Chain B)
            GEGTFTSDLS KQMEEEAVRL FIEWLKNGGP SSGAPPPS
            (Disulfide bridge: A3-A'3, A35-A95, A141-A199, A'35-A'95, A'141-A'199)
            (Covalent bridge: A1-B26)
  TYPE      Peptide
EFFICACY    Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist
COMMENT     Treatment of diabetes
TARGET      GLP1R [HSA:2740] [KO:K04581]
  PATHWAY   hsa04080(2740)  Neuroactive ligand-receptor interaction
            hsa04911(2740)  Insulin secretion
BRITE       Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Glucagon
                GLP1R
                 D11947  Efpeglenatide (USAN/INN)
DBLINKS     CAS: 1296200-77-5
///
